Related Experiment Video
Updated: Mar 16, 2026
09:57
Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model
Published on: April 1, 2019
7.7K
Engineered Tissue-Stent Biocomposites as Tracheal Replacements
Liping Zhao1, Sumati Sundaram2,1, Andrew V Le1
12 Department of Anesthesiology, Yale University , New Haven, Connecticut.
Tissue Engineering. Part A
|August 14, 2016
Summary
Researchers developed a novel tissue-stent biocomposite trachea (TSBT) for airway regeneration. This engineered trachea shows promising results in animal models, resisting collapse and integrating with host tissues.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Tracheal defects pose significant clinical challenges.
- Current tracheal replacement strategies often face limitations such as donor scarcity, immune rejection, and structural instability.
- The development of off-the-shelf, biocompatible tracheal substitutes is highly desirable.
Purpose of the Study:
- To engineer and evaluate a novel acellular tissue-stent biocomposite trachea (TSBT) as a potential tracheal replacement.
- To assess the biocompatibility, structural integrity, and regenerative capacity of TSBTs in preclinical animal models.
Main Methods:
- Culturing allogeneic or xenogeneic smooth muscle cells on a polyglycolic acid polymer-metal stent scaffold.
- Forming a tissue construct comprising cells, extracellular matrix, and stent material.
- Decellularizing the construct to create an acellular tissue-stent biocomposite trachea (TSBT).
- Implanting TSBTs as end-to-end tracheal replacements in rats and nonhuman primates for 8 weeks.
Main Results:
- TSBTs demonstrated structural integrity, resisting collapse and compression without perforation, infection, migration, or erosion.
- Histological analysis revealed adaptive remodeling with host cells, including connective tissue formation and epithelialization of the lumen.
- Some instances of airway stenosis were observed, indicating a need for further optimization.
Conclusions:
- Engineered TSBTs represent a promising acellular tracheal graft that integrates with host tissues and resists mechanical failure.
- The TSBT approach avoids the need for recipient-specific cells, offering a potential off-the-shelf solution for tracheal regeneration.
- Further research and optimization are warranted to address observed stenosis and advance TSBTs towards clinical application.
